Hemoglobinopathy and pediatrics in the time of COVID-19
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2021/01/01
-
Indian UGC (journal)
-
Refrences57
-
Citations17
-
Thiago de Souza Vilela ORCID (unauthenticated)
-
Josefina Aparecida Pellegrini Braga ORCID (unauthenticated)
-
Sandra Regina Loggetto ORCID (unauthenticated)
Cite
Vilela, Thiago de Souza, et al. “Hemoglobinopathy and Pediatrics in the Time of COVID-19”. Hematology, Transfusion and Cell Therapy, vol. 43, no. 1, 2021, pp. 87-100, https://doi.org/10.1016/j.htct.2020.11.002.
Vilela, T. de S., Braga, J. A. P., & Loggetto, S. R. (2021). Hemoglobinopathy and pediatrics in the time of COVID-19. Hematology, Transfusion and Cell Therapy, 43(1), 87-100. https://doi.org/10.1016/j.htct.2020.11.002
Vilela T de S, Braga JAP, Loggetto SR. Hemoglobinopathy and pediatrics in the time of COVID-19. Hematology, Transfusion and Cell Therapy. 2021;43(1):87-100.
Journal Categories
Medicine
Internal medicine
Neoplasms
Tumors
Oncology
Including cancer and carcinogens
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the blood and blood-forming organs
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Responding to Covid-19 - A once-in-a-century pandemic? | New England Journal of Medicine |
| 2020 | |
| Managing haematology and oncology patients during the COVID ‐19 pandemic: interim consensus guidance | Medical Journal of Australia |
| 88 | 2020 |
| Prevalence and mortality in β‐thalassaemias due to outbreak of novel coronavirus disease (COVID‐19): the nationwide Iranian experience | British Journal of Haematology |
| 24 | 2020 |
| COVID‐19 infection and sickle cell disease: a UK centre experience | British Journal of Haematology |
| 56 | 2020 |
| Patients with sickle cell disease and suspected COVID‐19 in a paediatric intensive care unit | British Journal of Haematology |
| 32 | 2020 |
Refrences Analysis
The category
Medicine: Internal medicine: Specialties of internal medicine: Diseases of the blood and blood-forming organs 32
is the most frequently represented among the references in this article. It primarily includes studies from British Journal of Haematology The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Case Fatality Rate and Severity of COVID-19 among Patients with Sickle Cell Disease: A Systematic Review and Meta-Analysis | Hemoglobin |
| 2023 | |
The impact of COVID-19 in children with Sickle Cell Disease: Results of a multicentric registry | PLOS ONE |
| 2023 | |
Clinical and laboratory differences between pediatric hospitalized patients with sickle cell disease infected or not by SARS-CoV-2 | Revista Paulista de Pediatria |
| 2023 | |
COVID-19 infection among pediatric patients with hemoglobinopathies in Basrah, Iraq | Iraqi Journal of Hematology |
| 2023 | |
Successful use of veno‐venous extracorporeal membrane oxygenation for acute chest syndrome in a child with sickle cell disease and SARS‐CoV‐2 | Pediatric Pulmonology |
| 2 | 2022 |
Citations Analysis
The category
Medicine: Medicine (General) 7
is the most commonly referenced area in studies that cite this article. The first research to cite this article was titled Coagulation Abnormalities and Clinical Complications in Children With SARS-CoV-2: A Systematic Review of 48,322 Patients and was published in 2021. The most recent citation comes from a 2023 study titled COVID-19 infection among pediatric patients with hemoglobinopathies in Basrah, Iraq. This article reached its peak citation in 2021, with 7 citations. It has been cited in 16 different journals, 43% of which are open access. Among related journals, the Journal of Pediatric Hematology/Oncology cited this research the most, with 2 citations. The chart below illustrates the annual citation trends for this article.